|
About UsTraxxsson uses proprietary protein biomarkers to provide non-invasive diagnostic tests that resolve diagnostic dilemmas in cancer. Its initial tests are focused on providing information to guide diagnosis and treatment decisions in urological, breast and lung cancer.
|
Traxxsson Provides
|
Guidance to minimize invasive testing to make a diagnosis
Guidance where currently there is no accurate way to determine whether aggressive treatment is required or not. Guidance to improve patient outcomes. Guidance to save patient function when treatment is not necessary. Guidance based on new ideas. Traxxsson’s tests are based on innovative concepts not available in current diagnostics |
